1. Home
  2. IRON vs BHE Comparison

IRON vs BHE Comparison

Compare IRON & BHE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$80.06

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Benchmark Electronics Inc.

BHE

Benchmark Electronics Inc.

HOLD

Current Price

$81.80

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
BHE
Founded
2017
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
IRON
BHE
Price
$80.06
$81.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
3
Target Price
$103.18
$55.00
AVG Volume (30 Days)
812.9K
581.8K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
0.94%
EPS Growth
N/A
N/A
EPS
N/A
0.36
Revenue
N/A
$2,659,108,000.00
Revenue This Year
N/A
$7.03
Revenue Next Year
$283.52
$6.57
P/E Ratio
N/A
$225.03
Revenue Growth
N/A
0.11
52 Week Low
$40.00
$34.44
52 Week High
$99.50
$100.41

Technical Indicators

Market Signals
Indicator
IRON
BHE
Relative Strength Index (RSI) 69.40 41.05
Support Level $70.29 $80.52
Resistance Level $82.70 $88.27
Average True Range (ATR) 3.14 4.75
MACD 0.81 -1.81
Stochastic Oscillator 73.44 16.06

Price Performance

Historical Comparison
IRON
BHE

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About BHE Benchmark Electronics Inc.

Benchmark Electronics Inc is engaged in product designing, engineering services, technology solutions, and manufacturing services (electronic manufacturing services (EMS) and precision technology services). It serves various industries, including aerospace & defense (A&D), medical technologies, complex industrials, semiconductor capital equipment, next-generation telecommunications, and high-end computing. Its geographical segments are the Americas, Asia, and Europe, of which key revenue is derived from the Americas.

Share on Social Networks: